A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Elman, Jessica S ^a   Li, Matthew ^b   Wang, Fangjing ^a   Gimble, Jeffrey M ^c   Parekkadan, Biju ^a,d  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

Adipose stem cells; Endotoxic shock; Mesenchymal stem cells; Soluble receptors; Tissue necrosis factor alpha (TNF ); Vascular endothelial growth factor (VEGF)

Indexed keywords

SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 1; SOLUBLE VASCULOTROPIN RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ADIPOSE TISSUE DERIVED MESENCHYMAL STROMA CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STROMA CELL; CELL DIFFERENTIATION; CELL POPULATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; SEPTIC SHOCK; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84892703540     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-11-1     Document Type: Article

References (24)

1. Customized probability models for early severe sepsis in adult intensive care patients. Intensive Care Unit Scoring Group. Le Gall J, Lemeshow S, Leleu G, Klar J, Huillard J, Rue M, Teres D, Artigas A, JAMA 1995 273 644 650 10.1001/jama.1995.03520320054041 7844875
2. The pathophysiology and treatment of sepsis. Hotchkiss RS, Karl IE, N Engl J Med 2003 348 138 150 10.1056/NEJMra021333 12519925
3. Soluble cytokine receptors: their role in immunoregulation. Fernandez-Botran R, Faseb J 1991 5 2567 2574 1868981
4. Mechanisms of soluble cytokine receptor generation. Levine SJ, J Immunol 2004 173 5343 5348 15494479
5. Cytokine inhibitors in autoimmune disease. Weckmann AL, Alcocer-Varela J, Semin Arthritis Rheum 1996 26 539 557 10.1016/S0049-0172(96)80042-4 8916298
6. Anti-TNF-alpha agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Silva LC, Ortigosa LC, Benard G, Immunotherapy 2010 2 817 833 10.2217/imt.10.67 21091114
7. Strategies for the treatment of sepsis. Warren HS, N Engl J Med 1997 336 952 953 10.1056/NEJM199703273361311 9070479
8. Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis. Tsao PN, Chan FT, Wei SC, Hsieh WS, Chou HC, Su YN, Chen CY, Hsu WM, Hsieh FJ, Hsu SM, Crit Care Med 2007 35 1955 1960 10.1097/01.CCM.0000275273. 56547.B8 17568329
9. Sepsis and the broken endothelium. Shapiro NI, Aird WC, Crit Care 2011 15 135 10.1186/cc10044 21457513
10. Mesenchymal stem cells as therapeutics. Parekkadan B, Milwid JM, Annu Rev Biomed Eng 2010 12 87 117 10.1146/annurev-bioeng-070909-105309 20415588
11. Defining human mesenchymal stem cell efficacy in vivo. Bonfield TL, Nolan Koloze MT, Lennon DP, Caplan AI, J Inflamm (Lond) 2010 7 51 10.1186/1476-9255-7-51 20974000
12. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, et al. Nat Med 2009 15 42 49 10.1038/nm.1905 19098906
13. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, Tilles AW, Tompkins RG, Parekkadan B, Yarmush ML, Mol Ther 2010 18 1857 1864 10.1038/mt.2010.155 20664529
14. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML, PLoS ONE 2007 2 941 10.1371/journal.pone.0000941 17895982
15. Human mesenchymal stem cells modulate allogeneic immune cell responses. Aggarwal S, Pittenger MF, Blood 2005 105 1815 1822 10.1182/blood-2004-04-1559 15494428
16. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J, Stem Cells Dev 2012 21 2724 2752 10.1089/scd.2011.0722 22468918
17. The comparition of biological characteristics and multilineage differentiation of bone marrow and adipose derived Mesenchymal stem cells. Zhu X, Shi W, Tai W, Liu F, Cell Tissue Res 2012 350 2 277 287 10.1007/s00441-012- 1453-1 22661317
18. Yield and characterization of subcutaneous human adipose-derived stem cells by flow cytometric and adipogenic mRNA analyzes. Yu GWX, Dietrich MA, Polk P, Scott LK, Ptitsyn AA, Gimble JM, Cytotherapy 2010 12 538 546 10.3109/14653241003649528 20380539
19. Isolation of human adipose-derived stem cells from lipoaspirates. Yu G, Floyd ZE, Wu X, Halvorsen YD, Gimble JM, Methods Mol Biol 2011 702 17 27 10.1007/978-1-61737-960-4-2 21082391
20. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML, Hepatology 2008 47 1634 1643 10.1002/hep.22236 18395843
21. Resistance to endotoxic shock and reduced neutrophil migration in mice deficient for the Src-family kinases Hck and Fgr. Lowell CA, Berton G, Proc Natl Acad Sci U S A 1998 95 7580 7584 10.1073/pnas.95.13.7580 9636192
22. The systemic inflammatory response syndrome. Robertson CM, Coopersmith CM, Microbes Infect 2006 8 1382 1389 10.1016/j.micinf.2005.12.016 16679040
23. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D, J Exp Med 1992 175 323 329 10.1084/jem.175.2.323 1310100
24. Endothelial cells form a phalanx to block tumor metastasis. Bautch VL, Cell 2009 136 810 812 10.1016/j.cell.2009.02.021 19269358